26 related news articles for Developmental and Cancer Biology

Hudson Institute’s Centre for Cancer Research is a major winner in the Medical Research Future Fund (MRFF) 2024 Paediatric Brain Cancer Research grants.…  Read more

At Hudson Institute, Minister for Medical Research Ben Carroll announced the establishment of the Victorian Paediatric Cancer Consortium Limited (VPCC Ltd), made possible by a $35 million investment from the Government and $10 million from the Children’s Cancer Foundation.…  Read more

Cancer remains the number-one disease-related killer of Australian children, so a new program at Hudson Institute of Medical Research has been established to specifically target one of the most deadly cancers – sarcoma.…  Read more

Cade Watts was only 15 when he died, but his family and friends are determined that his legacy will be large – their fundraiser for sarcoma research, Climbing for Cade, has made sure of that.…  Read more

Thanks to an extraordinary funding commitment, Hudson Institute of Medical Research will be home to the My Room Children’s Cancer Charity Fellowship and Laboratory.…  Read more

Hudson Institute researchers have had some great success in the recent NHMRC Grant rounds.…  Read more

A strangely named pathway that’s crucial to bone growth has emerged as a key in the fight to treat the bone cancer osteosarcoma.…  Read more

Hudson Institute’s Research Committee has announced this year’s recipients of the Science Innovation Seed Funding Awards.…  Read more

A new work of art in the foyer of Hudson Institute marks a new chapter in our history, as we look to our past and to the future with equal pride.…  Read more

When it comes to treating disease, the medical profession is increasingly recognising that children are not just small adults: their bodies behave differently. …  Read more

The future of children with cancer is brighter today, with the announcement of significant funding from the Victorian government for paediatric cancer research.…  Read more

It’s hard to imagine four words more frightening to a parent than “Your child has cancer”. Amid the fear and panic such a sentence creates, three-year-old Luca’s parents, Monique and Baden, had little choice but to trust in the best that medical science could offer.…  Read more

Some families are blessed to live lives free from the scourge of cancer … and then there are families like the Lordens. Four members of Ann Lorden’s family have endured their own battles with the dreaded disease – for a start, both Ann and her daughter are breast cancer survivors.…  Read more

Congratulations to Dr Vijesh Vaghjiani, Postdoctoral Scientist in the Developmental and Cancer Biology Research group who has been awarded one of two Sarcoma Research Grants by Australia and New Zealand Sarcoma Association (ANZSA).…  Read more

Six Early Career Researchers have been chosen for the 2021 Hudson Institute Emerging Leaders program.…  Read more

Bone cancer treatments will be progressed thanks to the Victorian Cancer Agency Early Career Fellowship, which has been awarded to Dr Vijesh Vaghjiani, Postdoctoral Scientist, Developmental and Cancer Biology Research group.…  Read more

In a world-first discovery, Hudson Institute cancer researchers have discovered two potential genetic markers which could be used to provide more personalised cancer treatments to some patients.…  Read more

Following a very successful CRH 3MT competition held via zoom last Wednesday, 20 May 2020, the prestigious judging panel, including Prof Jock Findlay, A/Prof Peter Stanton, Dr Tracey Edgell, Dr Rukmali Wijayarathna and Ann Scott, announced this year’s winners were…  Read more

A collection of data extracted from more than 1000 paediatric brain tumour samples will improve Hudson Institute scientists’ ability to tackle childhood brain cancer through targeted therapies. The new Paediatric Brain Tumour Atlas (PBTA), launched by the US-based Children’s Brain Tumour Tissue Consortium (CBTTC) on Monday, includes data collected from 30 unique childhood brain tumour…  Read more

A naturally occurring hormone could help make chemotherapy much more effective for many Australians with lung cancer, according to new findings from Sydney and Melbourne researchers. And the hormone – known as follistatin – also appears to prevent kidney damage, a serious side effect of chemotherapy. The promising new ‘two birds, one stone’ treatment approach, which was…  Read more

Dr Jason Cain has been awarded a Victorian Cancer Agency (VCA) Mid-Career Fellowship for his research to help tackle a rare and aggressive form of childhood cancer. Dr Cain was one of 14 successful VCA funding recipients announced by Acting Minister for Health, Martin Foley as part of a $7 million investment by the Victorian…  Read more

Hudson Institute scientists will share expertise with leading international research institutions to progress research and improve treatments for children and adolescents with brain cancer. Hudson Institute has been announced as the first Australian member of the US-based Children’s Brain Tumor Tissue Consortium (CBTTC) and joins a collaborative, multi-institutional research program dedicated to the study and…  Read more

Hudson Institute researchers have been awarded more than $10 million in funding by the National Health and Medical Research Council (NHMRC).…  Read more

Researchers at Hudson Institute of Medical Research are working to establish and pilot an Australian-first service for analysing the most common type of paediatric solid brain cancer tumour, medulloblastoma, to enable more effective treatment for these paediatric brain cancer patients.…  Read more

Researchers at Hudson Institute of Medical Research have discovered a crucial genetic marker that heralds better treatment and outcomes for patients with advanced bladder cancer.…  Read more

The Isabella and Marcus Paediatric Brainstem Tumour Fund have provided a grant of $84,000 to the Hudson Institute to support the work of Dr Jason Cain.…  Read more